News Conference News TVT 2022 No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest Michael O'Riordan June 09, 2022
News Conference News TVT 2021 Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market Todd Neale July 22, 2021
News Conference News TVT 2021 Timing of Mitral Surgery After Failed TEER Influences Outcomes Todd Neale July 21, 2021
News Conference News TVT 2020 Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years Michael O'Riordan June 22, 2020
News Conference News TVT 2020 Newer TAVR Devices Reassure in Failed Surgical Valves Shelley Wood June 20, 2020
News Conference News TVT 2019 Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery Michael O'Riordan June 20, 2019
News Conference News TVT 2019 Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results Shelley Wood June 19, 2019
News Conference News TVT 2019 Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR Michael O'Riordan June 19, 2019
News Conference News TVT 2019 Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI Michael O'Riordan June 17, 2019
News Conference News TVT 2019 Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry Shelley Wood June 17, 2019
News Conference News TVT 2019 What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches? Michael O'Riordan June 14, 2019
News Conference News TVT 2019 Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback Shelley Wood June 14, 2019
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019